# DIBBS #SPE2DS-27-T-1648

DLA request for Medline and 3M adhesive occlusive dressings

**Posted:** November 12, 2026
**Respond By:** November 17, 2026
**Identifier:** SPE2DS-27-T-1648
**NAICS:** 423450

DLA Troop Support is seeking sterile transparent adhesive dressings for medical use.
- Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain MD Surg FSF; buyer contact listed as Marc Canalichio.
- Requested item: adhesive occlusive dressing, NSN 6510-01-234-8943, for peripheral or central IV catheters or wound care.
  - Three line items request 1, 40, and 6 packages, respectively, for 47 packages total (100 dressings per package).
  - Each dressing must be clear, sterile, individually packaged, and measure 2.375 inches by 2.750 inches.
- Approved OEMs and part numbers:
  - Medline Industries, LP: MSC2302.
  - 3M Company: 1624, 1624 (IV Frame), and 1624W.
- Notable requirements: 36-month shelf life, with no more than five months between manufacture and delivery. Delivery is FOB destination to designated Navy vessels, required five days after award.

### Description

DRESSING, OCCLUSIVE, ADH (QTY: 1, NSN: 6510-01-234-8943, Purchase Request: 7019067363)
  Approved Sources:
  - CAGE: 0PMN3, Part No: MSC2302, Company: MEDLINE INDUSTRIES, LP
  - CAGE: 69892, Part No: 1624
  - CAGE: 69892, Part No: 1624 (IV FRAME)
  - CAGE: 69892, Part No: 1624W
 
DRESSING, OCCLUSIVE, ADH (QTY: 6, NSN: 6510-01-234-8943, Purchase Request: 7019111699)
  Approved Sources:
  - CAGE: 0PMN3, Part No: MSC2302, Company: MEDLINE INDUSTRIES, LP
  - CAGE: 69892, Part No: 1624
  - CAGE: 69892, Part No: 1624 (IV FRAME)
  - CAGE: 69892, Part No: 1624W
 
DRESSING, OCCLUSIVE, ADH (QTY: 40, NSN: 6510-01-234-8943, Purchase Request: 7019111981)
  Approved Sources:
  - CAGE: 0PMN3, Part No: MSC2302, Company: MEDLINE INDUSTRIES, LP
  - CAGE: 69892, Part No: 1624
  - CAGE: 69892, Part No: 1624 (IV FRAME)
  - CAGE: 69892, Part No: 1624W
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DS27T1648)
